Management of Osteoarthritis
- Authors: Mohamed A. Mokhtar, Mohamed A. Imam2, Florian Grubhofer3, Asser A. Sallam4
-
View Affiliations Hide Affiliations2 Department of Orthopaedics, University of Zurich, Balgrist University Hospital, Switzerland. 3 Department of Orthopaedics, University of Zurich, Balgrist University Hospital, Switzerland. 4 Department of Orthopaedics, University of Zurich, Balgrist University Hospital, Switzerland.
- Source: Bone Marrow Aspirate Concentrate and Expanded Stem Cell Applications in Orthopaedics , pp 60-67
- Publication Date: June 2018
- Language: English
Preview this chapter:
Management of Osteoarthritis, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781681086491/chapter-5-1.gif
Mesenchymal stem cells (MSCs) are perceived as an innovative approach to manage osteoarthritis (OA). There are anticipations that MSCs might improve symptoms, function, suppress inflammation and improve cartilage healing. Notwithstanding, the usage of MSCs in the treatment of osteoarthritis needs to be adequately represented, as there are many crucial determinants that should be considered before definitive reliable conclusions concerning the role of MSCs as a treatment option of OA can be drawn.
Hardbound ISBN:
9781681086507
Ebook ISBN:
9781681086491
-
From This Site
/content/books/9781681086491.chapter-5dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
/content/books/9781681086491.chapter-5
dcterms_subject,pub_keyword
-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData
10
5
Chapter
content/books/9781681086491
Book
false
en
